| ISIN | CH1106275048 |
|---|---|
| Valorennummer | 110627504 |
| Bloomberg Global ID | |
| Fondsname | Swiss Excellence DPM (CHF) Dis |
| Fondsanbieter |
NS Partners SA
Telefon: +41 22 906 52 50 E-Mail: reporting@nspgroup.com |
| Fondsanbieter | NS Partners SA |
| Vertreter in der Schweiz | |
| Distributor(en) |
Banque Cantonale Vaudoise Lausanne Telefon: +41 21 212 10 00 |
| Anlagekategorie | Aktienfonds |
| EFC-Kategorie | |
| Anteilskategorie | Distribution |
| Domizilland | Schweiz |
| Konditionen bei der Ausgabe | keine Ausgabekommission und/oder Gebühren zugunsten des Fonds (Ausgabe erfolgt zum Inventarwert) |
| Konditionen bei der Rücknahme | Keine Rücknahmekommission und/oder Gebühren zugunsten des Fonds (Rücknahme erfolgt zum Inventarwert) |
| Investment-Strategie *** | Swiss Excellence pursues the objective of outperforming the Swiss equity market as measured by the Swiss Leader Index® (SLI) Total Return. For the Sub-fund's main investment category, the asset manager integrates environmental, social, and governance (ESG) criteria into the stock selection process and towards the weighting of companies in the portfolio. The Sub-fund invests the majority of its assets into equities and security rights of companies having their registered office either located in Switzerland or carrying out a significant amount of their economic activity in Switzerland. Pensofinance SA, serving as an advisor, provides the asset manager with qualitative analyses of Swiss companies. |
| Besonderheiten |
| Aktueller Preis * | 126.34 CHF | 08.01.2026 |
|---|---|---|
| Vorheriger Preis * | 125.93 CHF | 07.01.2026 |
| 52 Wochen Hoch * | 126.34 CHF | 08.01.2026 |
| 52 Wochen Tief * | 100.88 CHF | 09.04.2025 |
| NAV * | 126.34 CHF | 08.01.2026 |
| Ausgabepreis * | ||
| Rücknahmepreis * | ||
| Schlusskurs * | ||
| Indikativer Minimalpreis | ||
| Fondsvermögen *** | 94'160'383 | |
| Anteilsklassevermögen *** | 46'878'351 | |
| Trading Information SIX | ||
| YTD-Performance | +1.46% |
31.12.2025 - 08.01.2026
31.12.2025 08.01.2026 |
|---|---|---|
| 1 Monat | +3.18% |
08.12.2025 - 08.01.2026
08.12.2025 08.01.2026 |
| 3 Monate | +4.32% |
08.10.2025 - 08.01.2026
08.10.2025 08.01.2026 |
| 6 Monate | +7.96% |
08.07.2025 - 08.01.2026
08.07.2025 08.01.2026 |
| 1 Jahr | +11.94% |
08.01.2025 - 08.01.2026
08.01.2025 08.01.2026 |
| 2 Jahre | +26.82% |
08.01.2024 - 08.01.2026
08.01.2024 08.01.2026 |
| 3 Jahre | +31.90% |
09.01.2023 - 08.01.2026
09.01.2023 08.01.2026 |
| 5 Jahre | +28.80% |
14.05.2021 - 08.01.2026
14.05.2021 08.01.2026 |
| Kapitalbeteiligungsquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anteil am Gesamtvermögen in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Immobilienquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Novartis AG Registered Shares | 6.31% | |
|---|---|---|
| Roche Holding AG | 6.15% | |
| UBS Group AG Registered Shares | 5.25% | |
| Nestle SA | 5.07% | |
| Swiss Re AG | 4.60% | |
| Compagnie Financiere Richemont SA Class A | 4.34% | |
| Zurich Insurance Group AG | 4.28% | |
| Lonza Group Ltd | 3.37% | |
| Givaudan SA | 3.28% | |
| Alcon Inc | 3.13% | |
| Letzte Daten-Aktualisierung | 31.07.2025 | |
| TER | 1.52% |
|---|---|
| Datum TER | 30.06.2025 |
| Performance Fee *** | 10.00% |
| PTR | |
| Max. Management Fee *** | 1.60% |
| Ongoing Charges *** | |
|
SRRI ***
|
|
| Datum SRRI *** | 31.12.2025 |